Launch excellence is rooted in the ability to understand and react to launch drivers in the marketplace, which of course change over time and differ from region to region.
Following white papers in September 2015 and February 2016, here Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.
This webinar delved into the challenges that pharma face when looking at their patient-centricity strategy, and the opportunities that exist with this approach.
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho